Masutani K et al. - A 52-year-old Japanese female admitted to hospital for microhematuria, proteinuria and progressive renal dysfunction was diagnosed with lung adenocarcinoma and multiple bone and brain metastases, and was treated with gefitinib (250 mg/day). Treatment for 6 months induced partial response with 30% regression of the primary lung tumor, and resolution of metastatic tumors.